Treatment of chronic hepatitis B
- 1 November 2001
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 1 (4) , 232-241
- https://doi.org/10.1016/s1473-3099(01)00118-9
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- L-dT: An ongoing phase I/IIa dose-escalation trial in patients with chronic HBV infection (NV-02B-001)Gastroenterology, 2001
- Antiviral l -Nucleosides Specific for Hepatitis B Virus InfectionAntimicrobial Agents and Chemotherapy, 2001
- Combination chemotherapy for hepatitis B virus: The final solution?Hepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Clinical Pharmacokinetics of LamivudineClinical Pharmacokinetics, 1999
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Thymosin α1 treatment of chronic hepatitis B: A multicenter, randomized, placebo-controlled double blind study: , KL Lindsay, ER Schiff, GD Cummings, HD Appelman. Wayne State Univ., Detroit, MI; Univ. of S. Cal., L.A., CA; Univ. of Miami, Miami, FL; Univ. of Michigan, Ann Arbor, MIGastroenterology, 1995
- Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trialJournal of Hepatology, 1994
- Treatment of Chronic Hepatitis B with Interferon: Experience in Asian PatientsSeminars in Liver Disease, 1989
- Transmission of HBsAg from mother to infant in four ethnic groups.BMJ, 1978